Amoeboid Migration Mode

Amoeboid Migration Mode is a form of single-cell locomotion through three-dimensional extracellular matrix (ECM) or tissue in which the cell adopts a rounded or ellipsoid morphology, relies primarily on actomyosin-driven cortical contractility and membrane blebbing rather than strong substrate adhesion, and moves by deforming its shape to squeeze through existing pores and gaps in the surrounding matrix rather than by proteolytically degrading it. It is one of the two principal single-cell invasion strategies used by migratory and cancerous cells — the other being mesenchymal migration — and is characterized by high speed, low adhesion, and protease independence.

Morphological and Molecular Signature

Amoeboid cells are rounded or weakly polarized, lacking the elongated, spindle-shaped morphology typical of mesenchymal migration. The cell cortex — a thin shell of cross-linked actin filaments and non-muscle myosin II lying just beneath the plasma membrane — is the dominant structural feature. High cortical actomyosin contractility, driven primarily through the RhoA–ROCK–myosin light chain kinase (MLCK) signaling axis, generates elevated intracellular (hydrostatic) pressure.

Rather than forming mature focal adhesions, amoeboid cells make only weak, short-lived, low-affinity contacts with the substrate, often mediated by friction rather than specific integrin-ligand bonds. This minimal adhesion dependence allows amoeboid cells to migrate efficiently even on substrates with low integrin ligand density, and to move independently of the strong traction forces required by mesenchymal cells.

Blebbing as the Driving Mechanism

The hallmark propulsive structure of amoeboid migration is the bleb: a spherical, membrane-bound protrusion formed when local cortical actin contraction increases hydrostatic pressure within the cytoplasm, causing the plasma membrane to locally detach from the underlying cortex (or rupture the cortex itself) and balloon outward, driven by cytoplasmic flow rather than actin polymerization at the tip. After initial expansion, a new actin cortex rapidly reassembles beneath the bleb membrane, and myosin II contraction at this new cortex retracts the bleb, providing net forward movement when this cycle is repeated asymmetrically toward the leading edge.

The bleb-based migration cycle proceeds as:

1. Local Cortex Weakening — Actin-myosin cortex detaches from the membrane or ruptures locally at the presumptive front.
2. Pressure-Driven Expansion — Cytosolic hydrostatic pressure, generated by cortical actomyosin contraction elsewhere in the cell, drives cytoplasm and membrane outward to form a bleb.
3. Cortex Reassembly — A new actin cortex polymerizes beneath the expanded bleb membrane within seconds.
4. Bleb Retraction and Force Generation — Myosin II contracts the newly formed cortex, retracting the bleb and generating forward traction against the confining matrix.

Confinement-Based Propulsion (Chimneying)

Because amoeboid cells generate minimal specific adhesion to the substrate, propulsion in confined three-dimensional environments often relies on a "chimneying" or friction-based mechanism: the cell exerts outward pushing force against the walls of a confining channel or matrix pore, and this friction against the confining geometry — rather than integrin-ligand traction — is sufficient to generate net forward movement, provided the cell is mechanically confined on multiple sides. This is why amoeboid migration is comparatively adhesion-independent but strongly dependent on physical confinement.

Protease Independence

A defining distinction from mesenchymal migration is that amoeboid cells do not require significant matrix metalloproteinase (MMP) activity to move. Instead of degrading collagen fibers to create a path, amoeboid cells deform their nucleus and cytoplasm to squeeze through pre-existing pores in the ECM network. Because the cell nucleus is typically the largest and stiffest organelle, its deformability — modulated by the nuclear lamina proteins (lamin A/C content) — is often the rate-limiting factor determining whether a cell can pass through a given pore size without protease-assisted widening.

Rho-GTPase Signaling Basis

High RhoA/ROCK activity, coupled with comparatively low Rac1 activity, favors the amoeboid phenotype, since Rac1-driven lamellipodial protrusion and integrin adhesion maturation are characteristic of the mesenchymal mode instead. This reciprocal balance between RhoA and Rac1 signaling is a central determinant of which migration mode a given cell adopts at a given time.

Plasticity: Mesenchymal-Amoeboid Transition

Amoeboid migration is not a fixed cell-intrinsic property but an interconvertible state. Cells can switch from mesenchymal to amoeboid migration (mesenchymal-amoeboid transition, MAT) in response to matrix metalloproteinase inhibition, increased matrix density, or elevated RhoA/ROCK signaling, and can revert (amoeboid-mesenchymal transition, AMT) when confinement is relieved or Rac1 signaling dominates. This plasticity allows invasive cancer cells to bypass therapies that target only one migratory mechanism, such as broad-spectrum MMP inhibitors, by adaptively switching to protease-independent amoeboid movement.

Comparison with Mesenchymal Migration

Relevance to Cancer Invasion and Metastasis

Amoeboid migration is observed in leukocytes under physiological conditions and is co-opted by numerous cancer types, including melanoma, small-cell lung carcinoma, and subsets of breast and prostate cancer cells, particularly following loss of integrin engagement, disruption of E-cadherin-independent adhesion complexes, or pharmacological/genetic MMP inhibition. Its high speed and independence from matrix-degrading enzymes make it a particularly difficult mode to therapeutically target, since it allows tumor cells to disseminate through tissue even when protease-based anti-invasive therapies are effective against mesenchymally migrating cells within the same tumor.

Experimental Assessment

Amoeboid migration is typically identified using three-dimensional collagen or dermal-equivalent invasion assays combined with live-cell imaging to visualize rounded morphology, bleb formation, and rapid, low-persistence trajectories. Key confirmatory criteria include insensitivity to broad-spectrum MMP inhibitors (e.g., GM6001), sensitivity to ROCK inhibitors (e.g., Y-27632) or myosin II inhibitors (e.g., blebbistatin), and dependence on physical confinement rather than substrate ligand density.